Back to top
Mabvinra 40 mg PFS
Mabvinra 40 mg PFS

Mabvinra 40 mg PFS

Mabvinra 40 mg PFS Specification

  • Origin of Medicine
  • Biological
  • Salt Composition
  • Bevacizumab 40 mg
  • Pacakaging (Quantity Per Box)
  • 1 prefilled syringe
  • Drug Type
  • Biological
  • Ingredients
  • Bevacizumab
  • Physical Form
  • Injection
  • Function
  • Treatment of certain types of cancers and eye disorders by inhibiting angiogenesis
  • Recommended For
  • Cancer and eye-related conditions requiring anti-angiogenic therapy
  • Dosage
  • 40 mg per prefilled syringe
  • Dosage Guidelines
  • Administer as prescribed by a healthcare professional typically under strict medical supervision
  • Suitable For
  • Adults
  • Quantity
  • 1 syringe per pack
  • Storage Instructions
  • Store in a refrigerator (2C - 8C). Do not freeze. Protect from light.
 
 

About Mabvinra 40 mg PFS



Mabvinra 40 mg PFS is a biological injection containing Bevacizumab, designed for the treatment of certain types of cancers and eye disorders by inhibiting angiogenesis. Each pack consists of 1 prefilled syringe with a dosage of 40 mg per syringe. It is recommended for adults and should be stored in a refrigerator between 2C - 8C, protected from light. The medication is to be administered under strict medical supervision as prescribed by a healthcare professional.

FAQs of Mabvinra 40 mg PFS:


Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Arthritis Category

Plamumab 40 mg PFS

Plamumab 40 mg PFS

Quantity : 1 prefilled syringe per pack

Recommended For : Rheumatoid arthritis psoriasis Crohns disease or other autoimmune conditions

Physical Form : Injection (Prefilled Syringe), Other

Pacakaging (Quantity Per Box) : 1 syringe

Origin of Medicine : Biotechnologyderived

Salt Composition : Plamumab 40 mg

Exemptia 40 mg PFS

Exemptia 40 mg PFS

Quantity : 1 prefilled syringe

Recommended For : Patients with autoimmune conditions as prescribed by a healthcare professional

Physical Form : Other, Injection

Pacakaging (Quantity Per Box) : 1 syringe per box

Origin of Medicine : Biotechnologyderived

Salt Composition : Adalimumab 40 mg

Actemra 162 mg PFS

Actemra 162 mg PFS

Quantity : 1 prefilled syringe

Recommended For : Patients with moderatetosevere rheumatoid arthritis polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis

Physical Form : Other, Injection

Pacakaging (Quantity Per Box) : 1 syringe per box

Origin of Medicine : Biologic Origin

Salt Composition : Tocilizumab 162 mg

Scapho 150 mg Injection

Scapho 150 mg Injection

Quantity : Single vial

Recommended For : Individuals with bacterial infections

Physical Form : Other, Injection

Pacakaging (Quantity Per Box) : 1 vial per box

Origin of Medicine : Allopathic

Salt Composition : Ceftriaxone Sodium